Amid turbulence and uncertainty on Wall Street, looking at recent insider trades can provide valuable insights, as executives ...

In the latest trading session, UnitedHealth Group (UNH) closed at $516.85, marking a +1.09% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.08% for the day.

Wells Fargo analyst Stephen Baxter maintained a Buy rating on UnitedHealth (UNH – Research Report) yesterday and set a price target of $660.00.

Wall Street analysts are throwing bouquets at UnitedHealth, with 23 out of 25 firms rating it a Strong Buy and the rest just ...

Buying $1000 In UNH: If an investor had bought $1000 of UNH stock 10 years ago, it would be worth $4,307.40 today based on a ...

According to the average brokerage recommendation (ABR), one should invest in UnitedHealth (UNH). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' ...

Optum Rx is cutting prior authorizations on 80 drugs and updating payment models to improve reimbursements, benefiting ...

Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities.

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” fourth quarter 2024 ...

UnitedHealth (UNH) stock in focus as the company's Optum Rx unit introduces cost-based payment models to address pharmacy challenges. Read more here.

UnitedHealth’s stock is trading at a premium compared to its industry peers, sparking debate on whether it remains a solid ...

Shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) have been assigned an average rating of “Buy” from the ...